Publications
5674 Results
- Journal / Conference
- Journal of Clinical Oncology 33:5s (suppl; abstr TPS3627); American Society of Clinical Oncology Annual Meeting (May 29-June 2, 2015, Chicago, IL), poster session;
- Year
- 2015
- Research Committee(s)
- Prevention, Screening, and and Surveillance
- Study Number(s)
- S0820
SWOG S0820/PACES (Preventing Adenomas of the Colon with Eflornithine and Sulindac), A Randomized, Double-Blind, Placebo-Controlled Phase III Clinical Trial - NCT01349881
- Journal / Conference
- Journal of Clinical Oncology 33:5s (suppl; abstr TPS9093); American Society of Clinical Oncology Annual Meeting (May 29-June 2, 2015, Chicago, IL), poster session;
- Year
- 2015
- Research Committee(s)
- Melanoma
- Study Number(s)
- S1320
SWOG S1320: A randomized phase II trial of intermittent versus continuous dosing of dabrafenib and trametinib in BRAFV600E/K mutant melanoma
- Journal / Conference
- Journal of Clinical Oncology 33:5s (suppl; abstr TPS9085); American Society of Clinical Oncology Annual Meeting (May 29-June 2, 2015, Chicago, IL), poster session;
- Year
- 2015
- Research Committee(s)
- Melanoma
- Study Number(s)
- S1404
SWOG S1404: A phase III randomized trial comparing high dose interferon to MK-3475 (pembrolizumab) in patients with high risk resected melanoma
- Journal / Conference
- Journal of Clinical Oncology 33:5s (suppl; abstr e17084); American Society of Clinical Oncology Annual Meeting (May 29-June 2, 2015, Chicago, IL), publication only;
- Year
- 2015
- Research Committee(s)
- Brain
- Study Number(s)
- SWOG-9005
SWOG S9005: double blind phase III randomized trial of the anti-progestin agent mifepristone in the treatment of unresectable meningioma
- Journal / Conference
- Journal of Clinical Oncology 33:5s (suppl; abstr 5008); American Society of Clinical Oncology Annual Meeting (May 29-June 2, 2015, Chicago, IL), oral presentation;
- Year
- 2015
- Research Committee(s)
- Genitourinary
- Study Number(s)
- SWOG-9346
Long term consequences of intermittent and continuous androgen deprivation in patients with metastatic prostate cancer
- Journal / Conference
- Journal of Clinical Oncology 33:5s (suppl; abstr LBA500); American Society of Clinical Oncology Annual Meeting (May 29-June 2, 2015, Chicago, IL), poster session;
- Year
- 2015
- Research Committee(s)
- Cancer Care Delivery
Creating a national collaborative strategy to enhance trial accrual in NCI’s National Clinical Trials Network (NCTN) in the era of precision medicine
- Journal / Conference
- Journal of Clinical Oncology 33:5s (suppl; abstr 3531); American Society of Clinical Oncology Annual Meeting (May 29-June 2,2015, Chicago, IL), poster session;
- Year
- 2015
- Research Committee(s)
- Gastrointestinal
- Study Number(s)
- CTSU/N0147
Relationship between metformin use and recurrence and survival in patients (pts) with resected stage III colon cancer (CC) Receiving Adjuvant Chemotherapy: Results from NCCTG N0147 (Alliance).
- Journal / Conference
- Journal of Clinical Oncology 33:5s (suppl; abstr 6504); American Society of Clinical Oncology Annual Meeting (May 29-June 2,2015, Chicago, IL), oral;
- Year
- 2015
- Research Committee(s)
- Gastrointestinal
- Study Number(s)
- CTSU/C80405
Cost of chemotherapy for metastatic colorectal cancer with either bevacizumab or cetuximab: economic analysis of CALGB/SWOG 80405
- Journal / Conference
- Journal of Clinical Oncology 33:5s (suppl; abstr 4005); American Society of Clinical Oncology Annual Meeting (May 29-June 2, 2015, Chicago, IL), oral;
- Year
- 2015
- Research Committee(s)
- Gastrointestinal
- Study Number(s)
- CTSU/C80701
Randomized phase II study of everolimus alone (E) versus everolimus plus bevacizumab (E+B) in patients with locally advanced or metastatic pancreatic neuroendocrine tumors, CALGB 80701
- Journal / Conference
- Journal of Clinical Oncology 33:5s (suppl; abstr TPS7583); American Society of Clinical Oncology Annual Meeting (May 29-June 2, 2015, Chicago, IL), poster session;
- Year
- 2015
- Research Committee(s)
- Lung
- Study Number(s)
- CTSU/E4512